Live Oak Private Wealth LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 9.6% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 31,688 shares of the healthcare conglomerate’s stock after selling 3,374 shares during the quarter. UnitedHealth Group makes up 1.5% of Live Oak Private Wealth LLC’s holdings, making the stock its 20th biggest holding. Live Oak Private Wealth LLC’s holdings in UnitedHealth Group were worth $10,942,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 48 shares during the last quarter. LFA Lugano Financial Advisors SA bought a new position in shares of UnitedHealth Group during the second quarter valued at $25,000. Sagard Holdings Management Inc. bought a new stake in shares of UnitedHealth Group in the second quarter worth $29,000. Islay Capital Management LLC bought a new position in shares of UnitedHealth Group during the second quarter worth about $31,000. Finally, Nova Wealth Management Inc. lifted its holdings in UnitedHealth Group by 339.1% in the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock valued at $53,000 after buying an additional 78 shares during the period. 87.86% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
UNH has been the topic of a number of research reports. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research report on Friday, September 12th. Bank of America lifted their target price on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Finally, The Goldman Sachs Group assumed coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price objective for the company. Seventeen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $385.54.
UnitedHealth Group Price Performance
NYSE UNH opened at $331.76 on Monday. The firm’s 50-day simple moving average is $333.71 and its two-hundred day simple moving average is $319.16. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The company has a market cap of $300.52 billion, a PE ratio of 17.32, a price-to-earnings-growth ratio of 2.16 and a beta of 0.43.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same period last year, the firm earned $7.15 EPS. UnitedHealth Group’s revenue for the quarter was up 12.2% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were issued a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio is 46.14%.
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
